CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
35.62
-0.52 (-1.44%)
At close: May 9, 2025, 4:00 PM
36.18
+0.56 (1.57%)
Pre-market: May 12, 2025, 8:49 AM EDT

CRISPR Therapeutics AG Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
-298.26389.48211.89923.031,169
Upgrade
Short-Term Investments
-1,6061,3041,6031,456521.71
Upgrade
Cash & Short-Term Investments
1,9041,9041,6941,8152,3791,690
Upgrade
Cash Growth
-9.69%12.41%-6.70%-23.70%40.75%79.10%
Upgrade
Accounts Receivable
-25200-0.310.14
Upgrade
Other Receivables
-2.16.511.28.410.7
Upgrade
Receivables
-27.1206.511.28.7110.84
Upgrade
Prepaid Expenses
-6.217.8926.0129.6815.44
Upgrade
Restricted Cash
---0.5--
Upgrade
Total Current Assets
-1,9371,9081,8532,4181,717
Upgrade
Property, Plant & Equipment
-277.55305.94320.56312.0493.03
Upgrade
Long-Term Investments
--1.9753.13--
Upgrade
Other Intangible Assets
--0.020.070.130.18
Upgrade
Other Long-Term Assets
-27.3513.5716.2822.218.14
Upgrade
Total Assets
-2,2422,2302,2432,7521,828
Upgrade
Accounts Payable
-14.7138.1527.4314.829.09
Upgrade
Accrued Expenses
-39.4140.6761.3377.7754.32
Upgrade
Current Portion of Leases
-17.2915.6315.8412.1611.36
Upgrade
Current Income Taxes Payable
-0.450.440.140.7210.47
Upgrade
Current Unearned Revenue
-3.854.11-1.012.34
Upgrade
Other Current Liabilities
-12.089.8116.3813.46.67
Upgrade
Total Current Liabilities
-87.78108.79121.11119.8894.26
Upgrade
Long-Term Leases
-206.41223.01228.18212.8750.07
Upgrade
Long-Term Unearned Revenue
-12.3214.0112.3212.3211.78
Upgrade
Other Long-Term Liabilities
-3.440.965.977.347.63
Upgrade
Total Liabilities
-309.95346.77367.58352.42163.73
Upgrade
Common Stock
-2.72.52.442.392.28
Upgrade
Additional Paid-In Capital
-3,2942,8782,7352,5982,236
Upgrade
Retained Earnings
--1,366-999.7-846.09-195.92-573.58
Upgrade
Treasury Stock
--0.06-0.06-0.06-0.06-0.06
Upgrade
Comprehensive Income & Other
-1.841.91-15.65-5.07-0.08
Upgrade
Total Common Equity
1,9321,9321,8831,8752,3991,664
Upgrade
Shareholders' Equity
1,9321,9321,8831,8752,3991,664
Upgrade
Total Liabilities & Equity
-2,2422,2302,2432,7521,828
Upgrade
Total Debt
223.69223.69238.63244.02225.0361.43
Upgrade
Net Cash (Debt)
1,6801,6801,4571,6242,1541,629
Upgrade
Net Cash Growth
-10.31%15.31%-10.30%-24.59%32.24%82.77%
Upgrade
Net Cash Per Share
19.6719.9218.3920.8926.7924.70
Upgrade
Filing Date Shares Outstanding
85.9485.7780.2878.6577.0775.43
Upgrade
Total Common Shares Outstanding
85.9485.7480.0478.5176.9973.91
Upgrade
Working Capital
-1,8491,7991,7322,2981,622
Upgrade
Book Value Per Share
22.5322.5323.5223.8931.1722.52
Upgrade
Tangible Book Value
1,9321,9321,8831,8752,3991,664
Upgrade
Tangible Book Value Per Share
22.5322.5323.5223.8931.1622.51
Upgrade
Machinery
-54.453.2649.6236.2529.5
Upgrade
Construction In Progress
-6.128.866.1652.48.37
Upgrade
Leasehold Improvements
-145.85143.26141.6886.7425.47
Upgrade
Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q